Device Endo-Mechanical

Echelon Endopath

Payments companies reported to CMS as associated with Echelon Endopath. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.4Massociated payments (2023-2025)

1,971clinicians with associated payments

7companies reporting

By year

2023 $514K

2024 $475K

2025 $367K

Payments reported as associated with Echelon Endopath, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $847K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $291K

Colon & Rectal Surgery $46K

Physician Assistant $33K

Internal Medicine $21K

Orthopaedic Trauma $15K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Echelon Endopath

These are the largest totals companies reported as associated with Echelon Endopath. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Elizabeth Dovec	Lakeland, FL	Surgery	$224,564.65
Mathew Ninan	Nashville, TN	Surgery	$100,386.11
Farah Husain	Portland, OR	Surgery	$62,246.41
Vadim Zeltsman	Great Neck, NY	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$61,822.71
Daniel Miller	Marietta, GA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$39,294.62
Jeffrey Hagen	Charlotte, NC	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$37,327.15
Alan Wittgrove	Del Mar, CA	Surgery	$29,695.18
Isaac Felemovicius	Maple Grove, MN	Colon & Rectal Surgery	$28,895.57
Emily Cassidy	Baton Rouge, LA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$27,453.69
Pearl Ma	Fresno, CA	Surgery	$27,185.28

Prescribed Echelon Endopath?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.